Selsun Shampoo 2.5%
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Selsun Shampoo 2.5%
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 100 ml of suspension contains 2.5 g of Selenium Sulphide Ph. Eur.
3 PHARMACEUTICAL FORM
Shampoo
Smooth, pale yellow to beige uniform suspension.
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
In the management of simple dandruff and seborrhoeic dermatitis of the scalp.
4.2 Posology and method of administration
Apply topically to the scalp.
Adults and the elderly:
After thoroughly wetting the hair massage Selsun in to form a lather. Rinse after 2 to 3 minutes.
Usage should be twice a week for the next two weeks to control the condition. After this initial course of treatment Selsun should not be used more often than necessary.
Children aged 5 - 14 years:
As for adults.
Children under 5 years of age:
Not recommended.
4.3 Contraindications
Hypersensitivity to any of the ingredients.
Do not allow contact with broken or severely inflamed skin.
4.4 Special warnings and precautions for use
Gold, silver and other metallic jewellery should be removed prior to use, since discoloration may be caused.
For external use only. Keep out of the eyes; if Selsun gets into the eyes, wash thoroughly with cold water.
Do not leave the shampoo in contact with the hair or skin for more than the recommended duration as irritation, burning sensation or blistering may occur and do not use more often than recommended (see Section 4.2).
4.5 Interaction with other medicinal products and other forms of interaction
Selsun should be very thoroughly rinsed from the hair before dyeing, tinting, or permanent waving the hair. It should not be applied for a period of two days before or after any of these procedures.
4.6 Fertility, pregnancy and lactation
There are no adequate data from the use of selenium sulphide in pregnant women. Animal studies are insufficient with respect to effects on pregnancy, foetal development and postnatal development.
Avoid during pregnancy and breastfeeding.
4.7 Effects on ability to drive and use machines
No studies on the effects on the ability to drive or use machines have been performed. .
4.8 Undesirable effects
Application to the skin or scalp may produce irritation or sensitisation, sometimes described as a burning sensation. Rarely, blistering can occur, especially if the shampoo is kept in contact with the skin for longer than the recommended duration.
An increase in the amount of normal hair loss can occur. Discoloration of the hair may occur; this can be avoided or minimised by thorough washing of the hair after treatment.
As with other shampoos, oiliness or dryness of hair and scalp may occur.
Non-specific allergic reactions, including rash and urticaria, have been reported rarely
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
4.9 Overdose
If ingested, vomiting should be provoked and general supportive measures given .
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Selenium sulphide appears to have a cytostatic effect on cells of the epidermis and follicular epithelium, thus reducing corneocyte production. Selsun acts as an antiseborrhoeic agent which effectively controls itching and scaling dandruff. It has activity against certain dermatophytes including Pityrosporum orbiculare, the organism causing pityriasis versicolor (tinea versicolor).
5.2 Pharmacokinetic properties
Not applicable.
Preclinical safety data
5.3
No additional preclinical information, relevant to the indication, is presented.
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Bentonite, titanium dioxide, citric acid, sodium dihydrogen phosphate dihydrate, glyceryl monoricinoleate S, monoethanolamine lauryl sulphate, Empigen BB, perfume, sodium chloride, sodium hydroxide for pH adjustment, purified water.
6.2 Incompatibilities
None known.
6.3 Shelf life 3 years.
6.4 Special precautions for storage
Do not store above 25 °C.
6.5 Nature and contents of container
High density polyethylene bottles fitted with wadless caps, containing 50, 100 or 150ml.
6.6 Special precautions for disposal
Not applicable.
MARKETING AUTHORISATION HOLDER
7
Aventis Pharma Limited
One Onslow Street
Guilford
Surrey
GU1 4YS
UK
Or trading as:
Sanofi-aventis or Sanofi
One Onslow Street
Guilford
Surrey
GU1 4YS
UK
8 MARKETING AUTHORISATION NUMBER(S)
PL 04425/0683
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
16 December 2002
10 DATE OF REVISION OF THE TEXT
31/07/2014